| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc6c2e9e63b6561f2f46b1de31f6379 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16 |
| filingDate |
2002-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_991133d07c2a397a49a9c6c0885d293d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e282ae25c49d233c6846ef7d7f943483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9758868f9cf64830fbd138d20e23c2c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5add933ee7236947f72c6cb6c471055d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a78796e2e7d241b93f16c053848f16e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2378774205ef44d83807ba2b9c0ceefa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2db765a45772da1ea625b7fc7b77eee |
| publicationDate |
2003-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1358155-A1 |
| titleOfInvention |
Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as mmp inhibitors |
| abstract |
This invention is directed to aromatic sulfonyl α-cycloamino hydroxamates (also known as aromatic sulfonyl α-cycloamino hydroxamic acids) of formula (I) that, inter alia, inhibit matrix metalloproteinase (also known as matrix metalloprotease or MMP) activity. This invention also is directed to a prevention or treatment method that comprises administering an aromatic sulfonyl α-cycloamino hydroxamate in an MMP-inhibiting effective amount to a mammal having (or disposed to having) a pathological condition associated with MMP activity. |
| priorityDate |
2001-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |